Evidence map›Paper›PMID 35928792›Full record

ArticleFrontiers in molecular neuroscience2022

Investigation of

Neven Maksemous, Claire D Blayney, Heidi G Sutherland, Robert A Smith, Rod A Lea, Kim Ngan Tran, Omar Ibrahim, Jeffrey R McArthur, Larisa M Haupt, M Zameel Cader and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. A Review of theDiseases (Basel, Switzerland) · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. CaHandbook of experimental pharmacology · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Neven MaksemousGenomics Research Centre, The Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Claire D BlayneyIllawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.
Heidi G SutherlandGenomics Research Centre, The Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Robert A SmithGenomics Research Centre, The Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Rod A LeaGenomics Research Centre, The Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Kim Ngan TranGenomics Research Centre, The Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Omar IbrahimGenomics Research Centre, The Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Jeffrey R McArthurIllawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.
Larisa M HauptGenomics Research Centre, The Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
M Zameel CaderWeatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom.
Rocio K Finol-UrdanetaIllawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.
David J AdamsIllawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.
Lyn R GriffithsGenomics Research Centre, The Centre for Genomics and Personalised Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia.
Queensland University of Technology · AUUniversity of Wollongong · AUUniversity of Oxford · GB

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853
6 · The paper itself

Abstract

Familial hemiplegic migraine (FHM) is a severe neurogenetic disorder for which three causal genes,

Indexed as

CACNA1ICav3.3familial hemiplegic migrainehemiplegic migraineion channelmigraine geneticsT-type calcium channelsvoltage gated calcium channels

Identifiers

PMID35928792
PMCPMC9345121
OpenAlexW4286218961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.